Study of JP-1366 tablets for heartburn and acid reflux
Part of Digestive system clinical trials.
This trial tests a new medication, JP-1366, for people with reflux esophagitis (damage to the esophagus from stomach acid). It aims to see if the drug is safe and effective at healing the esophagus and relieving symptoms like heartburn and regurgitation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had heartburn or regurgitation in the last 7 days, or a recent diagnosis of reflux esophagitis via endoscopy (a camera test of your esophagus).
- You are willing to use effective birth control during the study (if applicable).
- You do not have certain other gastrointestinal conditions, such as Barrett’s esophagus, active ulcers, or a history of surgery on your stomach or esophagus.
- You have not used strong acid-reducing medications (like Nexium or omeprazole) in the last 2 weeks, or certain other acid blockers in the last week.
- You do not have serious heart, liver, kidney, or bleeding problems that could increase risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
This study tests an investigational medication called JP-1366 for people with non-erosive GERD, a condition where acid reflux causes heartburn and regurgitation but no visible damage to the esophagus. The goal is to see if this new treatment can safely reduce symptoms better than a placebo.
This trial tests a new medication (JP-1366) to see if it helps prevent acid reflux damage from coming back. You may join if you have had erosive esophagitis that healed after treatment, and you are currently doing well without other serious conditions.
This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.
This trial is testing a device called RefluxStop™ that is implanted during keyhole surgery to treat acid reflux (GERD). The study will check how safe and effective the device is for people with long-term GERD, and it aims to help reduce heartburn and other reflux symptoms.
This study looks at how following specific diet and behavior changes affects symptoms of acid reflux (heartburn/regurgitation) in everyday life. It may help you understand what lifestyle steps improve reflux and how symptoms change over time.
Hear when a new Reflux Esophagitis (RE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.